AVITA Medical, Inc. reported the outcomes of its Annual Meeting held on June 3, 2026, where stockholders elected all seven directors, approved an increase in non-executive director cash fees from $750,000 to $900,000, and authorized various equity grants. A total of 15,592,447 shares voted at the meeting, representing a quorum.